NCI's Research on COVID-19, Vaccines, and Antibodies - NCI

What are COVID-19 antibodies, is there a certain level needed for protection, and how well do COVID-19 vaccines work in people with cancer? In this Q&A, NCI experts discuss emerging research findings from the SeroNet program that are shedding light on these and other important questions.

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

COVID-19 and Cancer: Researchers Work to Understand Immune Responses

Trends and patterns in cancer nanotechnology research: A survey of NCI's caNanoLab and nanotechnology characterization laboratory - ScienceDirect

Antibodies and Vaccines as Drugs for COVID-19, keystone symposia

New U of A-based study to examine very rare adverse events linked to COVID-19 vaccines

Preventive cancer vaccine based on neoantigens gets put to the test

g201503261017016651133.jpg

The Importance of Building Trust in COVID-19 Vaccines

The National Institutes of Health on LinkedIn: Vaccine-Induced Immune Response to Omicron Wanes Substantially Over Time

With $306M for serology research, NCI mobilizes labs, academic centers, grantees, contractors, and SBIR - The Cancer Letter

National Cancer Institute (NCI) on LinkedIn: Bacteria inside lung tumors concentrate within cancer cells

Antibodies and Vaccines as Drugs for COVID-19, keystone symposia

COVID-19 and Cancer: Current Challenges and Perspectives - ScienceDirect

An overview of selected molecular features of NCI‐60 cell lines. Shown

NCI's Research on COVID-19, Vaccines, and Antibodies - NCI